Pimenta EM, Garza AE, Camp SY, et al. Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity. Science translational medicine. 2026;18(833):eadw4689. doi:10.1126/scitranslmed.adw4689
Cancer Program
Jun H, Tanaka Y, Johri S, et al. A context-augmented large language model for accurate precision oncology medicine recommendations. Cancer cell. 2026. doi:10.1016/j.ccell.2025.12.017
Nadeem O, Aranha MP, Redd RA, et al. Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study. Nature communications. 2026. doi:10.1038/s41467-026-71483-z
Ibrahim KE, Mears KS, Allen PM, et al. In vivo CAR T cell generation using retargeted and functionalized lentiviral vectors with reduced immunogenicity. Nature communications. 2026. doi:10.1038/s41467-026-71395-y
Martin-Alonso C, Alamdari S, Samad TS, Yang KK, Bhatia SN, Amini AP. Deep learning guided design of protease substrates. Nature communications. 2026;17(1):54. doi:10.1038/s41467-025-67226-1
di Montesano SC, D’Ascenzo D, Raghavan S, Amini AP, Winter PS, Crawford L. Improving atlas-scale single-cell annotation models with hierarchical cross-entropy loss. Nature computational science. 2026. doi:10.1038/s43588-025-00945-z
Chung J, Vallurupalli M, Noel S, et al. Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity. Science (New York, N.Y.). 2026;392(6794):eady5196. doi:10.1126/science.ady5196
Manakongtreecheep K, Ctortecka C, Correa-Medero LO, et al. Sensitive detection of cancer antigens enabled by user-defined peptide libraries. Nature biotechnology. 2026. doi:10.1038/s41587-026-03003-9
Camp SY, He MX, Cuoco MS, et al. Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and loss. Science advances. 2026;12(8):eadv5457. doi:10.1126/sciadv.adv5457
Law CT, Burns KH. Comparative genomics reveals LINE-1 recombination with diverse RNAs. Cell genomics. 2026:101165. doi:10.1016/j.xgen.2026.101165